VYXEOS

NDC 68727-745 · Jazz Pharmaceuticals, Inc.

Generic name(daunorubicin and cytarabine) liposome

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION

RouteINTRAVENOUS

Active ingredient(s)CYTARABINE, DAUNORUBICIN

Strength100; 44 mg/20mL; mg/20mL

Pharmacologic classAnthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC], Topoisomerase Inhibitors [MoA]

Marketing categoryNDA

Packages

68727-745-01 — 20 mL in 1 VIAL (68727-745-01)

68727-745-02 — 40 mL in 1 CARTON (68727-745-02)

Billed under HCPCS

J9153 — Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine Medicare Part B payment limit (ASP + 6%): $272.89

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

25021-223 — cytarabine, 25021-229 — cytarabine, 61703-155 — CYTARABINE, 61703-303 — CYTARABINE, 61703-304 — CYTARABINE, 61703-305 — CYTARABINE, 61703-319 — CYTARABINE, 63323-120 — CYTARABINE, 68083-337 — Cytarabine, 68083-343 — Cytarabine, 71288-108 — Cytarabine, 71288-109 — Cytarabine, 71288-168 — Cytarabine, 71288-169 — Cytarabine

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels